Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 16 of about 8 companies and 8 funds for William R. Ward
Company Exchange Symbol Last price Quote change Market cap
SYSCO Corporation NYSE SYY 52.13 +0.04 (0.08%) 29.57B
Sysco Corporation (Sysco) along with its subsidiaries and divisions, is a North American distributor of food and related products primarily to the ...
Executive:
William B. Day
Baker Hughes Incorporated NYSE BHI 43.71 -0.84 (-1.89%) 19.17B
Baker Hughes Incorporated is engaged in the oilfield services industry. The Company is a supplier of oilfield services, products, technology and systems ...
Executive:
William H. Easter III.
Sangamo Biosciences, Inc. NASDAQ SGMO 5.76 -0.01 (-0.17%) 400.48M
Sangamo Biosciences Inc. is a clinical-stage biopharmaceutical company. The Company is focused on research, development and commercialization of engineered ...
Executive:
William ...
Cardiovascular Systems Inc NASDAQ CSII 18.85 -0.22 (-1.15%) 615.90M
Cardiovascular Systems, Inc. is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary arterial ...
Executive:
William E. Cohn MD.
Roadrunner Transportation Systems Inc NYSE RRTS 8.57 -0.23 (-2.61%) 326.54M
Roadrunner Transportation Systems, Inc. (RRTS) is an asset-light transportation and logistics service provider. The Company offers a suite of global supply ...
Executive:
William Goodgion.
Calithera Biosciences Inc NASDAQ CALA 3.17 +0.02 (0.63%) 61.65M
Calithera Biosciences, Inc. is a clinical-stage pharmaceutical company. The Company focuses on discovering and developing small molecule drugs directed ...
Executive:
William D. Waddill.
DATA Communications Management TSE DGI.UN 0.0000 88.56M
DATA Communications Management, formerly DATA Group Ltd, is a Canada-based company, which is focused on helping clients to plan and execute business ...
Executive:
William Albino.
Reata Pharmaceuticals Inc NASDAQ RETA 16.30 -0.51 (-3.03%) 335.45M
Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing, and commercializing product ...
Executive:
William E. Rose.
Mutual Fund Symbol Nav Nav change
MFS Diversified Income Fund Class A DIFAX 12.27 0.00 (0.00%)
The investment seeks total return with emphasis on current income, but also considering capital appreciation. The fund normally invests its assets primarily ...
Executive:
William J. Adams.
MFS Diversified Income Fund Class C DIFCX 12.26 -0.01 (-0.08%)
The investment seeks total return with emphasis on current income, but also considering capital appreciation. The fund normally invests its assets primarily ...
Executive:
William J. Adams.
MFS Diversified Income Fund Class I DIFIX 12.27 0.00 (0.00%)
The investment seeks total return with emphasis on current income, but also considering capital appreciation. The fund normally invests its assets primarily ...
Executive:
William J. Adams.
MFS Diversified Income Fund Class R2 DIFEX 12.26 -0.01 (-0.08%)
The investment seeks total return with emphasis on current income, but also considering capital appreciation. The fund normally invests its assets primarily ...
Executive:
William J. Adams.
MFS Diversified Income Fund Class R4 DIFGX 12.27 -0.01 (-0.08%)
The investment seeks total return with emphasis on current income, but also considering capital appreciation. The fund normally invests its assets primarily ...
Executive:
William J. Adams.
MFS Diversified Income Fund Class R1 DIFDX 12.25 0.00 (0.00%)
The investment seeks total return with emphasis on current income, but also considering capital appreciation. The fund normally invests its assets primarily ...
Executive:
William J. Adams.
MFS Diversified Income Fund Class R3 DIFFX 12.27 -0.01 (-0.08%)
The investment seeks total return with emphasis on current income, but also considering capital appreciation. The fund normally invests its assets primarily ...
Executive:
William J. Adams.
MFS Diversified Income Fund Class R5 DIFHX 12.27 0.00 (0.00%)
The investment seeks total return with emphasis on current income, but also considering capital appreciation. The fund normally invests its assets primarily ...
Executive:
William J. Adams.